Navigation Links
Use of opioids for pain in ERs on the rise, but racial differences in use still exist
Date:1/1/2008

oid prescribing was more likely for pain-related visits made by whites (31 percent) than by blacks (23 percent), Hispanics (24 percent), or Asians/others (28 percent), and there was no evidence of an interaction between the time trend and race/ethnicity during the study period. In 2005, opioid prescribing rates were 40 percent in whites and 32 percent in all others.

Differential opioid prescribing was consistently present across different types of pain, across different levels of pain severity, for visits in which pain was the first or second/third reason for visit, and for two specific painful diagnoses, long-bone fracture and kidney stones. Differences in prescribing between whites and nonwhites were larger as pain severity increased and were particularly pronounced for patients with back pain (48 percent vs. 36 percent, respectively), headache (35 percent vs. 24 percent), abdominal pain (32 percent vs. 22 percent), and other pain (40 percent vs. 28 percent). Blacks were prescribed opioids at lower rates than any other race/ethnicity group for almost every type of pain visit.

Statistical adjustment for pain severity and other factors did not substantially change these differences. Compared with white patients, black patients were 34 percent less likely to receive an opioid prescription; Hispanic patients, 33 percent less likely; and Asian/other patients, 21 percent less likely.

Our results suggest that new strategies are needed to understand and improve the quality and equity of management of acute pain in the United States. Future initiatives should continue to monitor pain management quality indicators and processes of care that may contribute to inadequate care, to educate physicians about the importance of adequate pain control, and to promote cultural competence within individual physicians. It is likely, however, that eliminating disparities in pain control will also require nonphysician interventions such as patient-targeted self
'/>"/>

Contact: Wallace Ravven
415-476-2557
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Cancer Patients Hold Fast to Belief That Opioids Mean Death
2. With Obesity, Diabetes, and Cardiovascular Disease on the Rise, Physicians Need More Comprehensive Guidelines
3. Mailman School of Public Health study examines link between racial discrimination and substance use
4. Can racial health disparities be effectively reduced?
5. Racial and ethnic differences in colorectal cancer emphasize importance of screening
6. No racial differences seen in outcomes after liver transplantation
7. Genetic differences point to ethnic and racial disparities in colorectal cancer risk
8. Racial and ethnic differences in the biology of breast cancer tumors
9. Survival differences by race most apparent in advanced stages of breast cancer
10. Gene Studies of Male-Female Differences Often Flawed
11. Major differences revealed in how local authorities in the UK support disabled people
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...ical ceramic company strengthens global team , ,... a subsidiary of the largest manufacturer of techn...at Dr. Steven Hughes has joined the company as Sal... , Steven will spearhead the business developmen...erks in Europe and Latin America in addition to su...
(Date:1/7/2009)...TLETON, Colo., Jan. 7 Zuma,s Rescu...month wait, and three years of being self funded, ...nations and sponsorship! , , Zuma,s Rescue Ran...ing a non-profit charity we have been working with...o cover Equine Assisted Psychotherapy for foster c...
(Date:1/7/2009)...ochelle, NY, January 6, 2009Dedicated to the memor...man, who pioneered the fields of angiogenesis and ...blood supply and neoplastic disease, the newly rel...of Lymphatic Research and Biology includes a ser...one of the pre-eminent physician-scientists of his...
(Date:1/7/2009)...BIA, Mo. There is no cure for spinal muscular atr...kening of muscles and is the leading genetic cause...rchers have discovered a new therapeutic target th...aused by SMA. The new therapy enhanced muscle stre...e lifespan in a SMA model. , "This therapy doe...
Breaking Medicine News(10 mins):Health News:Dr. Steven Hughes Joins Medical Ceramics Provider: C5 Medical Werks 2Health News:Festschrift Issue honoring Judah Folkman, M.D., in Lymphatic Research and Biology 2Health News:Researchers discover target that could ease spinal muscular atrophy symptoms 2
...h as it induces lot of alterations in the metaboli...s the risk of colorectal tumours, while drinking i.... // The study was conducted by Joseph C. Anders...Stony Brook University, Stony Brook, New York. 2,...
...e of Tropical Medicine has published the results o... said that the HIV virus has become less pathogeni...more sensitive to anti-retroviral drugs compared t...ch team compared the HIV samples collected in betw...
...ps to provide protection against lung cancer, acco...e believed to be responsible are plant-derived com...ts, grains, carrots, spinach, broccoli and other f...e University of Texas M.D. Anderson Cancer Center ...
...s lies at hand but that is the place no one looks....A weight control protein with a key role in the br...d new approaches for treating obesity and type 2 d... suggest that particular variants of the protein S...
Other Medicine News:Health News:Alcohol Consumption A Threat To Colorectal Tumours 2Health News:An Answer To Obesity: Weight Control Protein 2
(Date:1/7/2009)...ucts in Development Based On Osteotech,s Proprieta...BioRegeneration; FDA Filing Anticipated in Third Q...swire-FirstCall/ -- Osteotech, Inc. (Nasdaq: O...products for regenerative healing, announced today...r its DuraTech(TM) BioRegeneration Matrix. The fir...
(Date:1/6/2009)... In recent controlled studies cond...is , scientists found that the patented ingredient...only proven ingredient to increase levels of nitri... nitrate/nitrate (NOx) in human subjects. , , N...ncrease in blood flow to the skeletal muscles. Th...
(Date:1/6/2009)...nuary 6 , - Early...ion Until,December 2011 , - Expansion of t...,Discovery in Ophthalmology , - Revised Com...,Sublicenses to a Third Party , ExonHit T...einforcement,of its existing drug discovery colla...
(Date:12/30/2008)...PRNewswire-USNewswire/ -- The Coalition for 21st C...ion filed by Genentech, Inc. on December 5, 2008, ... offer diagnostic tests to physicians and patients...tests, would harm patient care and rests on flawed...on,s mission is to encourage the research, develop...
Breaking Medicine Technology:Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4UNC researchers find MSG use linked to obesity 4457 1UNC researchers find MSG use linked to obesity 4457 2Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results 25405 1Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results 25405 2Orbis Education Expands Nursing Education Program to Glendale California 25403 1Orbis Education Expands Nursing Education Program to Glendale California 25403 2Orbis Education Expands Nursing Education Program to Glendale California 25403 3Aon 3A Complex Insurance Requirements Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2834 1Aon 3A Complex Insurance Requirements Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2834 2Aon 3A Complex Insurance Requirements Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2834 3Aon 3A Complex Insurance Requirements Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2834 4
...007 /PRNewswire-FirstCall/ -- Boston,Scientific Co...icle,in the Journal of of Cardiology (JACC) review...s the Company,s second-generation,TAXUS(R) Liberte...le in the April 24 edition of JACC concluded that ...of the TAXUS Liberte Stent,system compared to the ...
...ta Presented at ASCO -, CHICAGO, June 04, 2007 /PR...y that Soliris(TM) (eculizumab), a new treatment f...oped by Alexion,Pharmaceuticals, Inc. , is effecti...ry of aplastic anemia (AA) or myelodysplastic,synd...od cell,destruction (hemolysis), decreased or elim...
Other Medicine Technology:Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 2Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 3Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 2Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 5Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 6Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 7
...to / MVR knife. 1.1 mm (19G) with a 1.38 mm width ...ca). State-of-the-art manufacturing and quality co...d precise. Sure grip handles have a ridge indicati... fluid tight incision for self-sealing wounds. Gau...
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro
Renu Multiplus preservative free lubricating and rewetting drops soothe and moisturize your eyes while you're wearing soft contact lenses. The gentle preservative free formula is ideal for eyes that
Medicine Products: